Tissue-Based PD-L1 Expression Is the Strongest Predictor of Overall Survival Benefit From ICI in Advanced Gastroesophageal Cancer. Zhang X, Ning C, Zhao H. JAMA Oncol 2023;9:280.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhang X, Ning C, Zhao H. Tissue-Based PD-L1 Expression Is the Strongest Predictor of Overall Survival Benefit From ICI in Advanced Gastroesophageal Cancer. JAMA Oncol 2023;9:280.
PMID: 36547972